BE24085 - Projections of Climate Risks, their Societal Impact and Cost, and the Cost and Effectiveness of Adaptation Measures for Water Scarcity

Award

Value

£296,168

Suppliers

Classifications

  • Research and development services and related consultancy services
  • Environmental Impact Assessment (EIA) services other than for construction

Tags

  • award
  • contract

Published

3 months ago

Description

UK Shared Business Services Limited (UK SBS) on behalf of the Climate Change Committee (CCC) invite you to this Request for Proposal for Projections of Climate Risks to Health and Health Services from Extreme Heat: Their Societal Impact and Cost, And the Cost and Effectiveness of Adaptation Measures.
The UK Climate Change Act 2008 requires that every five years, the UK government must publish a Climate Change Risk Assessment (CCRA). The Fourth UK Climate Change Risk Assessment (CCRA4) Government Report is due to be published in January 2027.
As part of CCRA4, the CCC will be developing a new output to complement the Technical Report as produced in previous CCRAs. This output - to be known as the 'Well-adapted UK report' (WA report) - will focus on the potential for key aspects of the UK adaptation challenge to reduce the climate risks threatening the achievement of key UK policy and societal outcomes and hence set out a vision for aspects of a well-adapted UK.
This WA report will be informed by a set of commissioned, bespoke analysis projects, in-house CCC analysis and wider external evidence. The analysis will need to be developed collaboratively with decision makers and consider both risk and adaptation interventions as systemically as possible, while focusing on delivering social and economic analysis and evidence at appropriate spatial scales.
This project is to focus on economy-wide water scarcity risks. Changing patterns of non-household water use, particularly in the context of Net Zero, are insufficiently understood. The analysis will answer the following questions:
• How is water demand (particularly for uses outside of the public water system) expected to change by sector, particularly in the context of efforts to reach Net Zero in the UK, and how will this vary by location?
• How will water scarcity risk (at times of drought) change in the UK, accounting for sectoral water demand as well as climate change, population growth and environmental water needs?
• Which adaptation actions are most effective in managing water scarcity risks, particularly outside of public water supply, and what package of adaptation actions could deliver an optimal level of resilience?

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete